The positive trend in the Hong Kong stock market, bolstered by a series of successful IPOs, enhances its allure to potential ...
They made the comments as the People's Bank of China, the country's central bank, together with other top regulators, ...
Last month, another Chinese beverage maker Guming, advised by Skadden, Shihui Partners and Ogier, also listed and raised $230 ...
ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial ...
China's central bank, together with other top financial regulators, convened a high-level symposium on Friday to discuss ...
China's central bank and financial regulators held a meeting with private enterprises and financial institutions, vowing to ...
The U.S. Securities and Exchange Commission (SEC) has recently changed its overall approach to crypto-related enforcement ...
About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.
Officials and economist said specific measures to be taken this year include incentivising State-owned capital investment in ...
China is expected to further ramp up reforms to bolster the country’s financial strength this year, a move of critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback